Clinical Trial Update: Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating SEVOREIN, an inhaled sevoflurane, in patients with end-stage kidney disease or acute kidney failure undergoing renal transplantation; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease
• Kidney Failure

Drugs mentioned

• SEVOREIN (sevoflurane)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: End-stage Chronic Renal Disease, Severe Acute Kidney Failure | Phase 3 | Status: COMPLETED